Skip to main content

Ad Scientiam tracks valuable digital biomarkers for clinical research

Ad Scientiam start-up has been focusing since 2013 on the collection of "valuable" digital biomarkers for clinical research and patient follow-up in several diseases, and is preparing to open "in the coming months" a subsidiary in the United States.

Read the article (in French)

Latest News

No news available.